Altimmune

Altimmune

Altimmune

Type
B2b
Founded
1997
Raised
$30.7M
Follow us
Alexa global traffic share
Latest funding
$14,700,000
Post-IPO equity - 2017
$16,000,000
Venture capital - 2015
Novartis Venture Fund Redmont Capital Truffle Capital +1
Team Size
1–10
Employees
$14,700,000 Post-IPO equity
HealthCap

Altimmune Announces $14.7 Million Series B Preferred Stock Offering